免疫万特 IMVT
$30.53 +$2.14 (+7.54%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $29.10 -4.68%
开盘$28.73
昨收$28.39
当日区间$28.34 – $30.61
成交量2.66M
市值$6.31B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q1, ended Jun 2026
营收$0.00
营业利润-$160.32M-26.0% YoY
净利润-$153.22M-27.0% YoY
摊薄每股收益-$0.75-5.6% YoY
自由现金流-$124.41M-6.0% YoY
经营现金流-$124.41M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-80.1%
资产收益率-71.1%
投入资本回报率-84.0%
流动比率7.27
负债/资产比率13.7%
现金及投资$797.80M
净现金（净负债）$797.80M
利润表
| 项目 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $160.32M | $532.90M | $159.55M | $114.36M | $131.76M |
| 销售及管理费用 | $17.69M | $76.24M | $17.27M | $15.44M | $17.51M |
| -管理费用 | $17.69M | $76.24M | $17.27M | $15.44M | $17.51M |
| 研发费用 | $142.63M | $456.66M | $142.29M | $98.92M | $114.25M |
| 营业利润 | -$160.32M | -$532.90M | -$159.55M | -$114.36M | -$131.76M |
| 非经营性利息净收入（支出） | $7.10M | $25.33M | $8.06M | $5.33M | $5.60M |
| 非经营性利息收入 | $7.10M | $25.33M | $8.06M | $5.33M | $5.60M |
| 其他收入（支出） | $4,000.00 | $2.18M | $798,000.00 | -$54,000.00 | $250,000.00 |
| 其他非经营性收入（支出） | $4,000.00 | $2.18M | $798,000.00 | -$54,000.00 | $250,000.00 |
| 税前利润 | -$153.22M | -$505.39M | -$150.70M | -$109.08M | -$125.91M |
| 税费 | $0.00 | $215,000.00 | -$2.84M | $1.55M | $594,000.00 |
| 净利润 | -$153.22M | -$505.61M | -$147.86M | -$110.64M | -$126.50M |
| 持续经营利润 | -$153.22M | -$505.61M | -$147.86M | -$110.64M | -$126.50M |
| 归属母公司净利润 | -$153.22M | -$505.61M | -$147.86M | -$110.64M | -$126.50M |
| 归属普通股股东净利润 | -$153.22M | -$505.61M | -$147.86M | -$110.64M | -$126.50M |
| 基本每股收益 | -$0.75 | -$2.77 | -$0.73 | -$0.61 | -$0.73 |
| 摊薄每股收益 | -$0.75 | -$2.77 | -$0.73 | -$0.61 | -$0.73 |
| 特殊收益（费用） | – | $0.00 | – | – | – |
| -减：重组及并购费用 | – | $0.00 | – | – | – |
资产负债表
| 项目 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| 总资产 | $852.49M | $957.01M | $957.01M | $1.05B | $582.96M |
| 流动资产合计 | $851.18M | $948.82M | $948.82M | $1.04B | $573.55M |
| 现金及现金等价物与短期投资 | $797.80M | $902.11M | $902.11M | $994.53M | $521.87M |
| -现金及现金等价物 | $797.80M | $902.11M | $902.11M | $994.53M | $521.87M |
| 应收款 | $697,000.00 | $3.95M | $3.95M | $1.64M | $1.97M |
| -应收账款 | $697,000.00 | $1.13M | $1.13M | $1.64M | $1.97M |
| 其他流动资产 | $52.68M | $42.76M | $42.76M | $46.77M | $49.71M |
| 非流动资产合计 | $1.31M | $8.20M | $8.20M | $9.45M | $9.41M |
| 固定资产净值 | $351,000.00 | $515,000.00 | $515,000.00 | $531,000.00 | $632,000.00 |
| 其他非流动资产 | $961,000.00 | $7.68M | $7.68M | $8.92M | $8.78M |
| 负债合计 | $117.10M | $104.42M | $104.42M | $66.26M | $63.25M |
| 流动负债合计 | $117.10M | $104.42M | $104.42M | $66.26M | $63.25M |
| 应付款 | $10.14M | $7.72M | $7.72M | $8.62M | $7.59M |
| -应付账款 | $10.14M | $7.54M | $7.54M | $8.62M | $6.92M |
| 一年内应计费用 | $101.71M | $79.87M | $79.87M | $42.34M | $45.19M |
| 非流动负债合计 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 股东权益合计 | $735.39M | $852.59M | $852.59M | $986.14M | $519.71M |
| 股东权益 | $735.39M | $852.59M | $852.59M | $986.14M | $519.71M |
| 股本 | $20,000.00 | $20,000.00 | $20,000.00 | $20,000.00 | $17,000.00 |
| -普通股 | $20,000.00 | $20,000.00 | $20,000.00 | $20,000.00 | $17,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $2.63B | $2.60B | $2.60B | $2.58B | $2.00B |
| 留存收益 | -$1.90B | -$1.75B | -$1.75B | -$1.60B | -$1.49B |
| 不影响留存收益的损益 | $725,000.00 | $730,000.00 | $730,000.00 | $1.20M | $1.45M |
| -应收税款 | – | $2.81M | $2.81M | – | – |
| -固定资产原值 | – | $515,000.00 | $515,000.00 | – | – |
| -一年内应付关联方款项 | – | $175,000.00 | $175,000.00 | $0.00 | $671,000.00 |
| 短期债务及融资租赁负债 | – | $72,000.00 | $72,000.00 | – | – |
| -一年内到期融资租赁负债 | – | $72,000.00 | $72,000.00 | – | – |
现金流量表
| 项目 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$124.41M | -$407.31M | -$95.06M | -$92.33M | -$102.52M |
| 持续经营经营活动现金流净额 | -$124.41M | -$407.31M | -$95.06M | -$92.33M | -$102.52M |
| 持续经营净利润 | -$153.22M | -$505.61M | -$147.86M | -$110.64M | -$126.50M |
| 折旧、折耗与摊销 | $92,000.00 | $409,000.00 | $96,000.00 | $101,000.00 | $105,000.00 |
| 其他非现金项目 | $27,000.00 | $99,000.00 | $26,000.00 | $25,000.00 | $24,000.00 |
| 营运资金变动 | $14.93M | $42.06M | $41.53M | $5.47M | $10.50M |
| -应收款变动 | $436,000.00 | -$1.40M | -$1.82M | $319,000.00 | -$25,000.00 |
| -预付资产变动 | -$4.95M | $8.84M | $4.31M | $2.87M | $1.16M |
| -应付账款及应计费用变动 | $12.68M | $34.65M | $37.84M | $2.32M | $9.19M |
| -其他流动资产变动 | $6.76M | $69,000.00 | $1.30M | -$38,000.00 | $167,000.00 |
| 筹资活动现金流 | $20.10M | $595.76M | $3.64M | $564.60M | $24.60M |
| 持续经营筹资活动现金流净额 | $20.10M | $595.76M | $3.64M | $564.60M | $24.60M |
| 股票期权行使所得 | $20.10M | $52.07M | $3.56M | $21.00M | $24.60M |
| 期末现金余额 | $797.80M | $902.11M | $902.11M | $994.53M | $521.87M |
| 现金净变动 | -$104.31M | $188.44M | -$91.43M | $472.28M | -$77.92M |
| 期初现金余额 | $902.11M | $713.97M | $994.53M | $521.87M | $598.91M |
| 汇率变动影响 | -$4,000.00 | -$299,000.00 | -$988,000.00 | $377,000.00 | $878,000.00 |
| 自由现金流 | -$124.41M | -$407.32M | -$95.07M | -$92.33M | -$102.52M |
| -其他流动负债变动 | – | -$99,000.00 | – | – | – |
| 投资活动现金流净额 | – | -$8,000.00 | -$8,000.00 | $0.00 | – |
| 持续经营投资活动现金流净额 | – | -$8,000.00 | -$8,000.00 | $0.00 | – |
| 固定资产购置及出售净额 | – | -$8,000.00 | -$8,000.00 | $0.00 | – |
| 普通股发行净额 | – | $544.19M | $0.00 | – | – |
| 其他筹资费用净额 | – | -$504,000.00 | $82,000.00 | – | – |
暂无评论——快来第一个聊聊 IMVT。
登录后参与讨论。